Ketogenic Diet for Refractory Status Epilepticus

Overview

About this study

This research is being done to observe the safety, tolerability, side effects, and effectiveness of the ketogenic diet in people with continuous seizures (status epilepticus) being treated in a neurointensive care unit.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients 18 years and older
  • In refractory status epilepticus (continuous or recurrent seizures without return to baseline mental status between seizures, lasting > 30 minutes)
  • Placed on anesthetics/sedating agents (barbiturates or benzodiazepines) after at least one first- and second-line agent failed to control seizures
  • With clinical and/or electrographic seizures following attempt to wean anesthetic/sedating agents after 24 hours.

 

Exclusion Criteria:

  • Unstable metabolic condition
  • Hemodynamic or cardiorespiratory instability
  • Coagulopathy
  • Liver failure
  • Total cholesterol > 300 mg/dL
  • Inability to tolerate enteral feeds, including ileus
  • Pregnancy
  • Family refusal/no consent
  • Received any propofol infusions within 24 hours
  • Known fatty acid oxidation disorder or pyruvate carboxylase deficiency

More information

Publications

Publications are currently not available
.
CLS-20209366

Mayo Clinic Footer